Prostate Neoplasms Recruiting Phase 2 Trials for Docetaxel (DB01248)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02649855Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate CancerTreatment